-+ 0.00%
-+ 0.00%
-+ 0.00%

Cantor Fitzgerald Reiterates Neutral on Amgen, Maintains $400 Price Target

Benzinga·09/08/2026 10:58:22
Listen to the news
Cantor Fitzgerald analyst Carter Gould reiterates Amgen (NASDAQ:AMGN) with a Neutral and maintains $400 price target.